Annual Non Current Assets
$3.27 M
+$2.06 M+171.49%
December 31, 2023
Summary
- As of February 18, 2025, MDGL annual long term assets is $3.27 million, with the most recent change of +$2.06 million (+171.49%) on December 31, 2023.
- During the last 3 years, MDGL annual non current assets has risen by +$1.43 million (+78.28%).
- MDGL annual non current assets is now -60.46% below its all-time high of $8.26 million, reached on December 31, 2005.
Performance
MDGL Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$9.60 M
+$1.54 M+19.08%
September 30, 2024
Summary
- As of February 18, 2025, MDGL quarterly long term assets is $9.60 million, with the most recent change of +$1.54 million (+19.08%) on September 30, 2024.
- Over the past year, MDGL quarterly non current assets has stayed the same.
- MDGL quarterly non current assets is now at all-time high.
Performance
MDGL Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
MDGL Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +171.5% | 0.0% |
| 3 y3 years | +78.3% | 0.0% |
| 5 y5 years | +1338.8% | 0.0% |
MDGL Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +171.5% | at high | +1008.4% |
| 5 y | 5-year | at high | +171.5% | at high | +1008.4% |
| alltime | all time | -60.5% | -100.0% | at high | -100.0% |
Madrigal Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.60 M(+19.1%) |
| Jun 2024 | - | $8.06 M(-3.2%) |
| Mar 2024 | - | $8.33 M(+155.0%) |
| Dec 2023 | $637.28 M(+76.4%) | $3.27 M(+30.9%) |
| Sep 2023 | - | $2.50 M(+188.1%) |
| Jun 2023 | - | $866.00 K(-25.7%) |
| Mar 2023 | - | $1.17 M(-3.2%) |
| Dec 2022 | $361.37 M(+33.0%) | $1.20 M(-21.5%) |
| Sep 2022 | - | $1.53 M(-17.0%) |
| Jun 2022 | - | $1.85 M(+23.7%) |
| Mar 2022 | - | $1.49 M(-9.5%) |
| Dec 2021 | $271.68 M(-4.7%) | $1.65 M(-5.3%) |
| Sep 2021 | - | $1.74 M(-7.8%) |
| Jun 2021 | - | $1.89 M(+12.0%) |
| Mar 2021 | - | $1.69 M(-8.0%) |
| Dec 2020 | $285.16 M(-35.2%) | $1.83 M(-9.1%) |
| Sep 2020 | - | $2.02 M(+12.9%) |
| Jun 2020 | - | $1.78 M(-9.4%) |
| Mar 2020 | - | $1.97 M(+6.0%) |
| Dec 2019 | $440.20 M(-9.3%) | $1.86 M(+99.5%) |
| Sep 2019 | - | $932.00 K(-10.1%) |
| Jun 2019 | - | $1.04 M(-11.4%) |
| Mar 2019 | - | $1.17 M(+415.4%) |
| Dec 2018 | $485.20 M(+152.7%) | $227.00 K(-7.0%) |
| Sep 2018 | - | $244.00 K(-4.3%) |
| Jun 2018 | - | $255.00 K(-8.6%) |
| Mar 2018 | - | $279.00 K(-7.3%) |
| Dec 2017 | $192.01 M(+366.0%) | $301.00 K(+171.2%) |
| Sep 2017 | - | $111.00 K(-7.5%) |
| Jun 2017 | - | $120.00 K(+2300.0%) |
| Mar 2017 | - | $5000.00(+66.7%) |
| Dec 2016 | $41.21 M(>+9900.0%) | $3000.00(-99.1%) |
| Sep 2016 | - | $316.50 K(+207.3%) |
| Jun 2016 | - | $103.00 K(-72.5%) |
| Mar 2016 | - | $374.00 K(>+9900.0%) |
| Dec 2015 | $363.60 K | $0.00(-100.0%) |
| Sep 2015 | - | $787.00 K(-20.7%) |
| Jun 2015 | - | $992.00 K(-30.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $1.42 M(+6.8%) |
| Dec 2014 | $99.35 M(+7.7%) | $1.33 M(-9.3%) |
| Sep 2014 | - | $1.47 M(-9.7%) |
| Jun 2014 | - | $1.62 M(-9.5%) |
| Mar 2014 | - | $1.79 M(-39.5%) |
| Dec 2013 | $92.24 M(-9.0%) | $2.96 M(+54.2%) |
| Sep 2013 | - | $1.92 M(-7.8%) |
| Jun 2013 | - | $2.08 M(+13.8%) |
| Mar 2013 | - | $1.83 M(+12.2%) |
| Dec 2012 | $101.39 M(+151.7%) | $1.63 M(-2.3%) |
| Sep 2012 | - | $1.67 M(+0.1%) |
| Jun 2012 | - | $1.67 M(-9.4%) |
| Mar 2012 | - | $1.84 M(-9.6%) |
| Dec 2011 | $40.29 M(-21.8%) | $2.04 M(+10.4%) |
| Sep 2011 | - | $1.85 M(-2.8%) |
| Jun 2011 | - | $1.90 M(-12.4%) |
| Mar 2011 | - | $2.17 M(-14.8%) |
| Dec 2010 | $51.52 M(+15.6%) | $2.55 M(-17.3%) |
| Sep 2010 | - | $3.08 M(-2.9%) |
| Jun 2010 | - | $3.17 M(-12.3%) |
| Mar 2010 | - | $3.61 M(-16.7%) |
| Dec 2009 | $44.57 M(-51.1%) | $4.34 M(-6.2%) |
| Sep 2009 | - | $4.62 M(-11.0%) |
| Jun 2009 | - | $5.19 M(-10.1%) |
| Mar 2009 | - | $5.78 M(-4.2%) |
| Dec 2008 | $91.22 M(-22.0%) | $6.03 M(+3.7%) |
| Sep 2008 | - | $5.82 M(-4.4%) |
| Jun 2008 | - | $6.08 M(+13.3%) |
| Mar 2008 | - | $5.37 M(-5.0%) |
| Dec 2007 | $117.00 M(+145.7%) | $5.65 M(+2.7%) |
| Sep 2007 | - | $5.50 M(-3.0%) |
| Jun 2007 | - | $5.68 M(-3.0%) |
| Mar 2007 | - | $5.85 M(-18.3%) |
| Dec 2006 | $47.63 M(-24.3%) | $7.16 M(+12.9%) |
| Sep 2006 | - | $6.34 M(-23.2%) |
| Dec 2005 | $62.95 M(-50.0%) | $8.26 M(+11.4%) |
| Mar 2005 | - | $7.42 M |
| Dec 2004 | $126.02 M(+63.5%) | - |
| Dec 2003 | $77.06 M | - |
FAQ
- What is Madrigal Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual non current assets year-on-year change?
- What is Madrigal Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly non current assets year-on-year change?
What is Madrigal Pharmaceuticals annual long term assets?
The current annual non current assets of MDGL is $3.27 M
What is the all time high annual non current assets for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual long term assets is $8.26 M
What is Madrigal Pharmaceuticals annual non current assets year-on-year change?
Over the past year, MDGL annual long term assets has changed by +$2.06 M (+171.49%)
What is Madrigal Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of MDGL is $9.60 M
What is the all time high quarterly non current assets for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly long term assets is $9.60 M
What is Madrigal Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, MDGL quarterly long term assets has changed by $0.00 (0.00%)